SCHEMBL13680926

SCHEMBL13680926

Cc1ccc(-c2nc(CCC=O)cs2)cc1

nearest known ligand 0.56

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
LMNA P02545 7/20 0.56
SMN1; SMN2 Q16637 3/20 0.56
MAPT P10636 4/20 0.51
TP53 P04637 5/20 0.50
ALDH1A1 P00352 1/20 0.48
RAB9A P51151 4/20 0.45
NPC1 O15118 3/20 0.45
SREBF2 Q12772 1/20 0.45
KDM4E B2RXH2 1/20 0.45
POLB P06746 1/20 0.44
MEN1 O00255 1/20 0.44
TSHR P16473 1/20 0.44
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
KMT2A Q03164 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13680922 0.85 GFER (0.62) LMNASMN1; SMN2MAPTTP53ALDH1A1
SCHEMBL13680943 0.85 RAB9A (0.48) LMNASMN1; SMN2MAPTTP53ALDH1A1
SCHEMBL13680920 0.84 RAB9A (0.56) LMNASMN1; SMN2MAPTALDH1A1RAB9A
SCHEMBL13680929 0.84 ALDH1A1 (0.62) LMNASMN1; SMN2MAPTTP53ALDH1A1
SCHEMBL13680955 0.83 GAA (0.42) LMNASMN1; SMN2MAPTTP53ALDH1A1
SCHEMBL13680932 0.83 KMT2A (0.47) LMNASMN1; SMN2MAPTTP53ALDH1A1
SCHEMBL13681039 0.82 MAPT (0.43) LMNASMN1; SMN2MAPTTP53ALDH1A1
SCHEMBL13681055 0.82 KDM4E (0.46) LMNASMN1; SMN2MAPTTP53ALDH1A1
SCHEMBL13680930 0.81 LMNA (0.55) LMNASMN1; SMN2MAPTTP53KDM4E
SCHEMBL13680937 0.81 KDM4E (0.52) LMNASMN1; SMN2MAPTTP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582658-B2 Bicyclic compound ASAHI KASEI PHARMA CORPORATION (JP) 2009-09-01 US disclosed
US-7582658-B2 Bicyclic compound ASAHI KASEI PHARMA CORPORATION (JP) 2009-09-01 US disclosed